Incorporating preemptive pharmacogenomic testing into the clinical setting.

Incorporating preemptive pharmacogenomic testing into the clinical setting. Clin Adv Hematol Oncol. 2020 Sep;18(9):526-529 Authors: O'Donnell PH PMID: 33006581 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33006581?dopt=Abstract

Source: Clinical Advances in Hematology and Oncology - October 4, 2020 Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research

More News: Cancer & Oncology | Hematology